The state of accounts receivable and accounts payable as a factor of ensuring financial stability at the enterprises of the pharmaceutical market of Russia

The pandemic period contributed to a significant increase in the revenue of pharmaceutical manufacturers and the growth of their business activity, however, in the conditions of the general economic crisis, ensuring the financial stability of pharmaceutical industry enterprises is influenced by a number of factors, primarily due to the management of receivables and payables and ensuring their high turnover. In the course of the study, the state of accounts receivable and accounts payable is assessed in the context of ten leading enterprises of the pharmaceutical market in Russia before and after the pandemic, established trends and their causes are identified. A feature of the industry is the fact that in all the studied enterprises there is an increase in revenue, in some cases several times. It was found that against the background of the overall growth in revenue and net profit in the largest manufacturers of pharmaceutical products, by 2021 there is also an increase in the total volume of both accounts receivable and accounts payable, which is a consequence of increased business activity against the background of growing demand for pharmaceutical products in an unfavorable epidemiological situation and mass vaccination. In 2021, only 4 enterprises accounted for more than 1 ruble of accounts receivable for 1 ruble of accounts receivable.